Rocket Lab USA (RKLB) Financials

$25.57 +0.35 (+1.39%)

Closing price 05/16/2025 04:00 PM Eastern

Extended Trading

$24.76 -0.81 (-3.17%)

As of 05/16/2025 08:00 PM Eastern

Annual Income Statements for Rocket Lab USA

This table shows Rocket Lab USA's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Net Income / (Loss) Attributable to Common Shareholders	-190	-183	-136	-117	-55
Consolidated Net Income / (Loss)	-190	-183	-136	-117	-55
Net Income / (Loss) Continuing Operations	-190	-183	-136	-117	-55
Total Pre-Tax Income	-189	-179	-133	-125	-55
Total Operating Income	-190	-178	-135	-102	-55
Total Gross Profit	116	51	19	-1.89	-12
Total Revenue	436	245	211	62	35
Operating Revenue	436	245	211	62	35
Total Cost of Revenue	320	193	192	64	47
Operating Cost of Revenue	320	193	192	64	47
Total Operating Expenses	306	229	154	100	43
Selling, General & Admin Expense	132	110	89	58	24
Research & Development Expense	174	119	65	42	19
Total Other Income / (Expense), net	0.39	-1.00	2.26	-23	0.41
Interest & Investment Income	-3.95	-4.25	-7.80	-6.13	0.22
Other Income / (Expense), net	4.34	3.25	10	-17	0.19
Income Tax Expense	0.76	3.65	3.00	-7.52	0.47
Basic Earnings per Share	($0.38)	($0.38)	($0.29)	($0.56)	($0.73)
Weighted Average Basic Shares Outstanding	495.93M	481.77M	466.21M	209.90M	75.41M
Diluted Earnings per Share	($0.38)	($0.38)	($0.29)	($0.56)	($0.73)
Weighted Average Diluted Shares Outstanding	495.93M	481.77M	466.21M	209.90M	75.41M
Weighted Average Basic & Diluted Shares Outstanding	453.55M	489.14M	477.65M	209.90M	75.41M

This table shows Rocket Lab USA's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-61	-52	-52	-42	-44	-50	-41	-46	-46	-33	-35
Consolidated Net Income / (Loss)	-61	-52	-52	-42	-44	-50	-41	-46	-46	-37	-35
Net Income / (Loss) Continuing Operations	-61	-52	-52	-42	-44	-50	-41	-46	-46	-33	-35
Total Pre-Tax Income	-61	-52	-51	-42	-44	-49	-39	-45	-45	-38	-33
Total Operating Income	-59	-52	-52	-43	-43	-48	-39	-45	-46	-37	-32
Total Gross Profit	35	37	28	27	24	15	15	15	6.36	1.83	8.47
Total Revenue	123	132	105	106	93	60	68	62	55	52	63
Operating Revenue	123	132	105	106	93	60	68	62	55	52	63
Total Cost of Revenue	87	96	77	79	69	44	53	47	49	50	55
Operating Cost of Revenue	87	96	77	79	69	44	53	47	49	50	55
Total Operating Expenses	94	88	80	70	67	63	54	60	52	39	40
Selling, General & Admin Expense	39	40	32	31	29	26	27	29	28	24	23
Research & Development Expense	55	48	48	40	39	37	27	31	24	15	18
Total Other Income / (Expense), net	-2.24	-0.12	0.90	0.78	-1.18	-1.60	-0.36	0.03	0.93	-1.00	-0.92
Interest & Investment Income	-2.59	-1.78	-0.45	-0.82	-0.90	-1.41	-1.41	-0.75	-0.69	-0.89	-1.49
Other Income / (Expense), net	0.35	1.66	1.36	1.61	-0.28	-0.20	1.06	0.78	1.61	-0.10	0.57
Income Tax Expense	-0.81	0.68	0.94	-0.86	0.01	1.01	1.35	0.76	0.53	-5.16	1.69
Basic Earnings per Share	($0.12)	($0.11)	($0.10)	($0.08)	($0.09)	($0.10)	($0.08)	($0.10)	($0.10)	($0.08)	($0.07)
Weighted Average Basic Shares Outstanding	505.61M	495.93M	497.70M	494.19M	489.99M	481.77M	484.03M	479.74M	476.20M	466.21M	469.77M
Diluted Earnings per Share	($0.12)	($0.11)	($0.10)	($0.08)	($0.09)	($0.10)	($0.08)	($0.10)	($0.10)	($0.08)	($0.07)
Weighted Average Diluted Shares Outstanding	505.61M	495.93M	497.70M	494.19M	489.99M	481.77M	484.03M	479.74M	476.20M	466.21M	469.77M
Weighted Average Basic & Diluted Shares Outstanding	461.43M	453.55M	499.91M	496.64M	492.78M	489.14M	485.89M	483.33M	478.66M	477.65M	473.26M

This table details how cash moves in and out of Rocket Lab USA's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Net Change in Cash & Equivalents	109	-79	-446	638	-44
Net Cash From Operating Activities	-49	-99	-107	-72	-28
Net Cash From Continuing Operating Activities	-49	-99	-107	-72	-28
Net Income / (Loss) Continuing Operations	-190	-183	-136	-117	-55
Consolidated Net Income / (Loss)	-190	-183	-136	-117	-55
Depreciation Expense	34	30	30	11	9.34
Amortization Expense	0.19	-1.67	1.43	1.55	0.00
Non-Cash Adjustments To Reconcile Net Income	88	88	61	52	15
Changes in Operating Assets and Liabilities, net	19	-33	-63	-19	3.05
Net Cash From Investing Activities	-98	12	-346	-92	-37
Net Cash From Continuing Investing Activities	-98	12	-346	-92	-37
Purchase of Property, Plant & Equipment	-67	-55	-42	-26	-25
Acquisitions	0.00	-19	-66	-66	-12
Purchase of Investments	-162	-207	-260	0.00	0.00
Sale of Property, Plant & Equipment	13	3.66	0.00	-	-
Sale and/or Maturity of Investments	116	269	22	0.00	0.00
Other Investing Activities, net	2.14	20	0.00	0.00	-
Net Cash From Financing Activities	257	7.37	2.04	800	21
Net Cash From Continuing Financing Activities	257	7.37	2.04	800	21
Repayment of Debt	-58	-104	4.38	0.00	0.00
Repurchase of Common Equity	-35	-16	-31	0.00	0.00
Issuance of Debt	0.00	110	0.00	99	0.00
Issuance of Preferred Equity	355	0.00	0.00	-	21
Other Financing Activities, net	-4.74	17	29	701	0.98
Effect of Exchange Rate Changes	-0.60	0.04	4.37	2.13	-
Cash Interest Paid	16	16	11	3.99	0.00
Cash Income Taxes Paid	0.27	0.77	2.67	1.84	-0.30

This table details how cash moves in and out of Rocket Lab USA's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	33	-21	-48	-25	203	22	-56	-11	-34	-90	-210
Net Cash From Operating Activities	-54	-2.39	-31	-13	-2.59	-42	-25	-6.06	-25	-19	-23
Net Cash From Continuing Operating Activities	-54	-2.39	-31	-13	-2.59	-42	-25	-6.05	-25	-19	-24
Net Income / (Loss) Continuing Operations	-61	-52	-52	-42	-44	-50	-41	-46	-46	-37	-35
Consolidated Net Income / (Loss)	-61	-52	-52	-42	-44	-50	-41	-46	-46	-37	-35
Depreciation Expense	8.71	9.14	8.10	8.11	8.31	8.17	7.79	6.75	7.03	8.36	7.85
Amortization Expense	0.27	0.19	0.15	0.05	-0.20	-0.43	-0.55	-0.25	-0.44	-0.25	0.29
Non-Cash Adjustments To Reconcile Net Income	23	81	-18	10	14	44	20	12	12	36	11
Changes in Operating Assets and Liabilities, net	-26	-40	30	10	20	-44	-12	21	1.72	-26	-8.53
Net Cash From Investing Activities	-29	-18	-17	-11	-52	61	-32	-6.22	-11	-73	-189
Net Cash From Continuing Investing Activities	-29	-18	-17	-11	-52	61	-32	-6.22	-11	-73	-189
Purchase of Property, Plant & Equipment	-29	-22	-11	-15	-19	-10	-21	-11	-13	-15	-8.35
Purchase of Investments	-85	-13	-36	-34	-79	-	-75	-56	-76	-80	-180
Sale of Property, Plant & Equipment	0.02	-	-	-	-	-	-	-	-	-	-
Sale and/or Maturity of Investments	85	13	29	28	46	50	65	76	78	21	0.24
Net Cash From Financing Activities	116	0.18	-0.44	-1.76	259	2.51	0.86	1.95	2.06	0.47	2.14
Net Cash From Continuing Financing Activities	116	0.18	-0.44	-1.76	259	2.51	0.86	1.95	2.06	-0.42	-19
Repayment of Debt	-3.17	46	-3.03	-3.59	-98	-104	-	-	0.00	-	-
Repurchase of Common Equity	-17	-20	-5.69	-4.32	-5.16	-3.37	-5.38	-5.05	-1.92	-2.86	-52
Issuance of Debt	27	-4.10	1.43	2.16	0.51	106	1.26	1.32	1.20	-3.15	-
Issuance of Preferred Equity	0.00	-	-	-	355	-	-	-	0.00	-	-
Issuance of Common Equity	91	-	-	-	-	-	-	-	-	-	-
Other Financing Activities, net	17	-22	6.84	3.98	5.97	3.67	4.99	5.68	2.77	1.21	30
Effect of Exchange Rate Changes	0.27	-1.36	0.90	0.38	-0.52	0.48	0.04	-0.61	0.13	-	-
Cash Interest Paid	9.58	2.05	9.65	2.32	2.27	4.81	3.69	3.63	3.42	3.16	2.82
Cash Income Taxes Paid	0.21	-0.21	0.08	0.38	0.03	0.20	0.19	0.07	0.32	0.15	0.49

This table presents Rocket Lab USA's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Total Assets	1,184	941	989	981	188
Total Current Assets	693	477	662	775	93
Cash & Equivalents	271	163	243	691	53
Short-Term Investments	148	82	229	0.00	-
Accounts Receivable	36	35	37	14	2.73
Inventories, net	119	108	92	48	26
Prepaid Expenses	55	67	52	19	9.41
Other Current Assets	63	22	9.45	2.49	2.05
Plant, Property, & Equipment, net	195	145	102	65	50
Total Noncurrent Assets	297	319	225	141	45
Long-Term Investments	61	79	9.19	0.00	-
Noncurrent Note & Lease Receivables	14	15	16	0.00	-
Goodwill	71	71	71	43	3.13
Intangible Assets	59	68	80	57	11
Noncurrent Deferred & Refundable Income Taxes	3.01	3.50	3.90	5.86	2.40
Other Noncurrent Operating Assets	89	82	46	34	28
Total Liabilities & Shareholders' Equity	1,184	941	989	981	188
Total Liabilities	802	387	316	282	80
Total Current Liabilities	340	223	163	96	48
Short-Term Debt	12	18	2.91	2.83	0.00
Accounts Payable	53	29	12	3.49	3.37
Accrued Expenses	19	5.59	8.72	11	6.57
Current Deferred Revenue	216	139	108	-	-
Current Employee Benefit Liabilities	21	16	8.63	8.27	4.58
Other Current Liabilities	18	15	22	71	34
Total Noncurrent Liabilities	462	163	153	186	31
Long-Term Debt	389	88	100	97	0.00
Noncurrent Deferred & Payable Income Tax Liabilities	0.89	0.43	0.10	0.47	0.00
Other Noncurrent Operating Liabilities	72	75	53	88	31
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	382	555	673	698	108
Total Preferred & Common Equity	382	555	673	698	-167
Preferred Stock	0.00	0.00	0.00	-	275
Total Common Equity	382	555	673	698	-167
Common Stock	1,199	1,177	1,113	1,002	20
Retained Earnings	-814	-624	-441	-305	-188
Accumulated Other Comprehensive Income / (Loss)	-2.81	1.54	1.14	1.31	1.06

This table presents Rocket Lab USA's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	1,255	1,153	1,189	1,182	950	981	991	1,001
Total Current Assets	725	695	752	726	506	560	635	699
Cash & Equivalents	303	292	341	366	141	197	208	333
Short-Term Investments	125	150	156	127	148	144	190	169
Accounts Receivable	39	22	50	31	23	25	51	58
Inventories, net	126	114	105	100	102	102	98	86
Prepaid Expenses	71	67	81	79	68	64	63	44
Other Current Assets	61	49	19	23	24	28	24	9.06
Plant, Property, & Equipment, net	214	171	156	148	136	120	96	94
Total Noncurrent Assets	316	287	281	308	308	301	260	208
Long-Term Investments	84	61	46	69	82	74	48	9.75
Noncurrent Note & Lease Receivables	14	15	15	15	15	15	15	16
Goodwill	71	71	71	71	71	71	71	60
Intangible Assets	56	62	64	67	70	73	76	83
Noncurrent Deferred & Refundable Income Taxes	3.77	1.42	1.57	3.35	3.28	3.64	3.50	3.24
Other Noncurrent Operating Assets	87	77	83	84	66	64	45	37
Total Liabilities & Shareholders' Equity	1,255	1,153	1,189	1,182	950	981	991	1,001
Total Liabilities	824	733	733	703	365	370	351	311
Total Current Liabilities	348	269	266	232	304	306	197	161
Short-Term Debt	20	12	11	11	105	104	2.93	2.89
Accounts Payable	70	42	26	26	25	26	23	13
Accrued Expenses	12	8.06	12	9.09	6.00	6.49	8.68	9.59
Current Deferred Revenue	207	167	184	151	134	135	126	113
Current Employee Benefit Liabilities	22	19	14	14	15	14	12	8.56
Other Current Liabilities	16	20	19	22	19	20	25	14
Total Noncurrent Liabilities	476	464	467	471	61	65	154	149
Long-Term Debt	404	47	50	53	0.00	0.00	101	99
Noncurrent Deferred & Payable Income Tax Liabilities	1.03	0.73	0.62	0.53	0.31	0.24	0.17	0.02
Other Noncurrent Operating Liabilities	71	416	416	417	61	64	53	50
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	431	420	455	479	586	611	640	700
Total Preferred & Common Equity	431	420	455	479	586	611	640	691
Preferred Stock	0.01	-	-	-	-	-	-	-
Total Common Equity	431	420	455	479	586	611	640	700
Common Stock	1,308	1,179	1,165	1,149	1,161	1,145	1,126	1,099
Retained Earnings	-874	-761	-709	-668	-573	-532	-487	-404
Treasury Stock	0.00	-	-	-	-	-	-	-
Accumulated Other Comprehensive Income / (Loss)	-2.37	2.31	-0.78	-1.80	-2.38	-1.76	0.57	4.36

This table displays calculated financial ratios and metrics derived from Rocket Lab USA's official financial filings.

Metric	2024	2023	2022	2021	2020
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Growth Metrics	-	-	-	-	-
Revenue Growth	78.34%	15.92%	239.02%	77.01%	0.00%
EBITDA Growth	-3.42%	-56.34%	11.80%	-134.06%	0.00%
EBIT Growth	-6.17%	-39.57%	-5.42%	-116.78%	0.00%
NOPAT Growth	-6.68%	-31.59%	-32.48%	-85.71%	0.00%
Net Income Growth	-4.17%	-34.30%	-15.87%	-113.29%	0.00%
EPS Growth	0.00%	-31.03%	48.21%	23.29%	0.00%
Operating Cash Flow Growth	50.55%	7.20%	-48.40%	-158.64%	0.00%
Free Cash Flow Firm Growth	38.73%	41.44%	-128.34%	0.00%	0.00%
Invested Capital Growth	-9.41%	13.79%	174.29%	94.04%	0.00%
Revenue Q/Q Growth	19.90%	3.48%	13.01%	0.00%	0.00%
EBITDA Q/Q Growth	-0.14%	-8.21%	-53.72%	0.00%	0.00%
EBIT Q/Q Growth	-0.99%	-6.56%	-41.54%	0.00%	0.00%
NOPAT Q/Q Growth	-1.97%	-6.37%	-10.54%	0.00%	0.00%
Net Income Q/Q Growth	-0.98%	-7.85%	-42.29%	0.00%	0.00%
EPS Q/Q Growth	-2.70%	-5.56%	-1,066.67%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	44.89%	-30.78%	2.71%	-27.70%	0.00%
Free Cash Flow Firm Q/Q Growth	-147.00%	-5.24%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	1,308.69%	4.78%	5.19%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-
Gross Margin	26.63%	21.02%	9.00%	-3.04%	-33.61%
EBITDA Margin	-34.76%	-59.93%	-44.44%	-170.82%	-129.19%
Operating Margin	-43.51%	-72.74%	-64.08%	-163.97%	-156.29%
EBIT Margin	-42.52%	-71.41%	-59.31%	-190.74%	-155.75%
Profit (Net Income) Margin	-43.60%	-74.64%	-64.43%	-188.51%	-156.44%
Tax Burden Percent	100.40%	102.04%	102.26%	93.98%	100.86%
Interest Burden Percent	102.13%	102.43%	106.23%	105.16%	99.59%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-41.51%	-39.47%	-46.99%	-87.61%	-69.36%
ROIC Less NNEP Spread (ROIC-NNEP)	-2.90%	-20.02%	-38.47%	-73.36%	-38.03%
Return on Net Nonoperating Assets (RNNOA)	0.92%	9.73%	27.17%	58.53%	18.55%
Return on Equity (ROE)	-40.59%	-29.74%	-19.82%	-29.09%	-50.81%
Cash Return on Invested Capital (CROIC)	-31.63%	-52.37%	-140.13%	-151.58%	0.00%
Operating Return on Assets (OROA)	-17.45%	-18.10%	-12.71%	-20.31%	-29.15%
Return on Assets (ROA)	-17.89%	-18.92%	-13.80%	-20.08%	-29.28%
Return on Common Equity (ROCE)	-40.59%	-29.74%	-19.82%	-19.17%	78.25%
Return on Equity Simple (ROE_SIMPLE)	-49.73%	-32.92%	-20.19%	-16.80%	32.99%
Net Operating Profit after Tax (NOPAT)	-133	-125	-95	-71	-38
NOPAT Margin	-30.46%	-50.92%	-44.86%	-114.78%	-109.40%
Net Nonoperating Expense Percent (NNEP)	-38.61%	-19.45%	-8.53%	-14.26%	-31.33%
Return On Investment Capital (ROIC_SIMPLE)	-16.95%	-18.87%	-12.19%	-8.95%	-35.53%
Cost of Revenue to Revenue	73.37%	78.98%	91.00%	103.04%	133.61%
SG&A Expenses to Revenue	30.16%	45.08%	42.19%	93.83%	68.24%
R&D to Revenue	39.98%	48.67%	30.89%	67.11%	54.44%
Operating Expenses to Revenue	70.14%	93.76%	73.08%	160.93%	122.68%
Earnings before Interest and Taxes (EBIT)	-185	-175	-125	-119	-55
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-152	-147	-94	-106	-45
Valuation Ratios	-	-	-	-	-
Price to Book Value (P/BV)	33.29	4.85	2.65	7.90	0.00
Price to Tangible Book Value (P/TBV)	50.37	6.47	3.41	9.23	0.00
Price to Revenue (P/Rev)	29.19	10.99	8.46	88.63	10.93
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	41.59	7.35	4.76	45.77	10.93
Enterprise Value to Revenue (EV/Rev)	29.01	10.09	6.66	79.14	17.25
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-
Debt to Equity	1.05	0.19	0.15	0.14	0.00
Long-Term Debt to Equity	1.02	0.16	0.15	0.14	0.00
Financial Leverage	-0.32	-0.49	-0.71	-0.80	-0.49
Leverage Ratio	2.27	1.57	1.44	1.45	1.74
Compound Leverage Factor	2.32	1.61	1.53	1.52	1.73
Debt to Total Capital	51.21%	15.96%	13.26%	12.54%	0.00%
Short-Term Debt to Total Capital	1.54%	2.69%	0.37%	0.35%	0.00%
Long-Term Debt to Total Capital	49.68%	13.27%	12.89%	12.18%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	254.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	48.79%	84.04%	86.74%	87.46%	-154.00%
Debt to EBITDA	-2.65	-0.72	-1.10	-0.94	0.00
Net Debt to EBITDA	0.52	1.49	4.03	5.56	0.00
Long-Term Debt to EBITDA	-2.57	-0.60	-1.07	-0.92	0.00
Debt to NOPAT	-3.02	-0.85	-1.09	-1.40	0.00
Net Debt to NOPAT	0.59	1.76	3.99	8.27	0.00
Long-Term Debt to NOPAT	-2.93	-0.70	-1.06	-1.36	0.00
Altman Z-Score	8.77	3.21	3.17	11.78	1.01
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	34.08%	254.00%
Liquidity Ratios	-	-	-	-	-
Current Ratio	2.04	2.13	4.06	8.04	1.92
Quick Ratio	1.34	1.25	3.12	7.32	1.15
Cash Flow Metrics	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-101	-165	-282	-124	0.00
Operating Cash Flow to CapEx	-89.62%	-193.68%	-251.20%	-279.35%	-110.49%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-
Asset Turnover	0.41	0.25	0.21	0.11	0.19
Accounts Receivable Turnover	12.18	6.82	8.35	7.46	12.88
Inventory Turnover	2.82	1.93	2.74	1.73	1.80
Fixed Asset Turnover	2.56	1.98	2.53	1.08	0.71
Accounts Payable Turnover	7.77	9.34	24.66	18.71	13.95
Days Sales Outstanding (DSO)	29.96	53.53	43.70	48.93	28.34
Days Inventory Outstanding (DIO)	129.40	189.07	133.24	210.70	203.06
Days Payable Outstanding (DPO)	46.96	39.10	14.80	19.51	26.17
Cash Conversion Cycle (CCC)	112.39	203.50	162.15	240.12	205.23
Capital & Investment Metrics	-	-	-	-	-
Invested Capital	304	336	295	108	55
Invested Capital Turnover	1.36	0.78	1.05	0.76	0.63
Increase / (Decrease) in Invested Capital	-32	41	188	52	0.00
Enterprise Value (EV)	12,655	2,468	1,406	4,925	606
Market Capitalization	12,733	2,687	1,784	5,516	384
Book Value per Share	$0.77	$1.14	$1.42	$1.55	($4.39)
Tangible Book Value per Share	$0.51	$0.86	$1.10	$1.33	($4.77)
Total Capital	784	660	776	799	108
Total Debt	401	105	103	100	0.00
Total Long-Term Debt	389	88	100	97	0.00
Net Debt	-78	-219	-378	-591	-53
Capital Expenditures (CapEx)	55	51	42	26	25
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-54	26	30	-9.68	-8.10
Debt-free Net Working Capital (DFNWC)	365	271	502	681	45
Net Working Capital (NWC)	353	253	499	678	45
Net Nonoperating Expense (NNE)	57	58	41	46	17
Net Nonoperating Obligations (NNO)	-78	-219	-378	-591	-53
Total Depreciation and Amortization (D&A)	34	28	31	12	9.34
Debt-free, Cash-free Net Working Capital to Revenue	-12.34%	10.77%	14.44%	-15.55%	-23.03%
Debt-free Net Working Capital to Revenue	83.71%	110.84%	238.04%	1,094.66%	127.12%
Net Working Capital to Revenue	80.95%	103.58%	236.67%	1,090.12%	127.12%
Earnings Adjustments	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.38)	($0.38)	($0.29)	($0.56)	$0.00
Adjusted Weighted Average Basic Shares Outstanding	495.93M	481.77M	466.21M	464.78M	0.00
Adjusted Diluted Earnings per Share	($0.38)	($0.38)	($0.29)	($0.56)	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	495.93M	481.77M	466.21M	464.78M	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	($0.56)	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	453.55M	489.14M	477.65M	209.90M	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-133	-125	-95	-71	-38
Normalized NOPAT Margin	-30.46%	-50.92%	-44.86%	-114.78%	-109.40%
Pre Tax Income Margin	-43.42%	-73.15%	-63.01%	-200.59%	-155.11%
Debt Service Ratios	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-18.58%	-8.61%	-22.92%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Rocket Lab USA's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	32.13%	120.68%	54.90%	71.25%	68.99%	15.90%	7.30%	11.85%	34.87%	88.38%	1,092.68%
EBITDA Growth	-41.48%	-0.53%	-38.40%	11.54%	6.78%	-38.07%	-31.24%	-31.95%	-201.19%	-924.11%	72.09%
EBIT Growth	-35.72%	-3.77%	-33.70%	6.12%	2.36%	-28.81%	-20.27%	-19.77%	-129.70%	-6,173.28%	63.74%
NOPAT Growth	-37.39%	-7.66%	-33.56%	4.17%	6.38%	-28.64%	-21.43%	-36.19%	-40.21%	-52.97%	38.80%
Net Income Growth	-36.95%	-3.66%	-28.03%	9.28%	2.97%	-35.72%	-17.21%	-22.64%	-70.79%	-1,264.21%	60.66%
EPS Growth	-33.33%	-10.00%	-25.00%	20.00%	10.00%	-25.00%	-14.29%	-25.00%	-66.67%	-133.33%	82.05%
Operating Cash Flow Growth	-1,995.25%	94.35%	-22.67%	-114.38%	89.81%	-122.83%	-9.58%	84.15%	3.62%	13.54%	-72.97%
Free Cash Flow Firm Growth	-241.24%	93.97%	560.80%	598.79%	388.24%	65.25%	79.34%	-69.53%	-1,332.10%	0.00%	-218.05%
Invested Capital Growth	1,961.71%	-9.41%	-107.85%	-108.85%	-106.20%	13.79%	14.23%	10.22%	29.00%	174.29%	1,375.55%
Revenue Q/Q Growth	-7.42%	26.31%	-1.36%	14.54%	54.63%	-11.34%	9.05%	13.02%	6.05%	-17.91%	13.67%
EBITDA Q/Q Growth	-22.93%	4.10%	-26.23%	4.94%	12.64%	-32.03%	19.32%	-0.18%	-29.39%	-25.51%	18.89%
EBIT Q/Q Growth	-17.94%	1.28%	-21.30%	3.90%	9.83%	-27.19%	14.83%	0.05%	-18.97%	-18.76%	15.18%
NOPAT Q/Q Growth	-14.82%	0.67%	-19.93%	-0.45%	10.03%	-23.22%	13.95%	1.86%	-23.63%	-16.31%	3.49%
Net Income Q/Q Growth	-15.80%	-0.78%	-24.76%	5.94%	12.35%	-24.48%	11.60%	-0.60%	-22.60%	-7.51%	7.50%
EPS Q/Q Growth	-9.09%	-10.00%	-25.00%	11.11%	10.00%	-25.00%	20.00%	0.00%	-25.00%	-14.29%	12.50%
Operating Cash Flow Q/Q Growth	-2,171.68%	92.28%	-137.81%	-402.32%	93.87%	-67.52%	-315.58%	76.11%	-33.99%	17.62%	39.89%
Free Cash Flow Firm Q/Q Growth	-8,910.03%	-101.45%	4.31%	3.96%	484.40%	-10.54%	-12.92%	39.93%	53.66%	34.27%	-826.58%
Invested Capital Q/Q Growth	12.76%	1,308.69%	5.29%	-44.23%	-105.49%	4.78%	6.74%	1.10%	0.63%	5.19%	2.99%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	28.76%	27.81%	26.71%	25.56%	26.06%	25.82%	22.12%	23.52%	11.58%	3.54%	13.43%
EBITDA Margin	-40.68%	-30.64%	-40.35%	-31.54%	-38.00%	-67.26%	-45.16%	-61.05%	-68.88%	-56.46%	-36.93%
Operating Margin	-48.29%	-38.94%	-49.52%	-40.73%	-46.44%	-79.82%	-57.43%	-72.78%	-83.83%	-71.91%	-50.75%
EBIT Margin	-48.01%	-37.69%	-48.22%	-39.22%	-46.74%	-80.15%	-55.87%	-71.53%	-80.89%	-72.11%	-49.85%
Profit (Net Income) Margin	-49.45%	-39.54%	-49.56%	-39.18%	-47.71%	-84.17%	-59.96%	-73.96%	-83.10%	-71.88%	-54.89%
Tax Burden Percent	98.68%	101.31%	101.85%	97.98%	100.01%	102.04%	103.45%	101.69%	101.17%	97.36%	105.14%
Interest Burden Percent	104.39%	103.56%	100.90%	101.98%	102.07%	102.92%	103.74%	101.68%	101.54%	102.39%	104.73%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-97.04%	-37.15%	-85.39%	-68.05%	-65.91%	-43.31%	-31.61%	-41.23%	-50.12%	-52.74%	-51.30%
ROIC Less NNEP Spread (ROIC-NNEP)	-90.49%	-26.19%	-80.99%	-65.19%	-62.56%	-37.62%	-27.71%	-37.43%	-46.95%	-50.44%	-49.11%
Return on Net Nonoperating Assets (RNNOA)	58.21%	8.30%	57.20%	48.45%	46.98%	18.28%	14.75%	21.25%	28.91%	35.63%	39.86%
Return on Equity (ROE)	-38.83%	-28.85%	-28.18%	-19.60%	-18.93%	-25.03%	-16.87%	-19.99%	-21.21%	-17.11%	-11.44%
Cash Return on Invested Capital (CROIC)	-147.38%	-31.63%	0.00%	0.00%	0.00%	-52.37%	-52.24%	-48.93%	-64.73%	-140.13%	0.00%
Operating Return on Assets (OROA)	-18.36%	-15.47%	-16.68%	-11.81%	-12.15%	-20.31%	-13.53%	-16.69%	-17.79%	-15.45%	-9.51%
Return on Assets (ROA)	-18.91%	-16.23%	-17.14%	-11.80%	-12.40%	-21.33%	-14.52%	-17.26%	-18.27%	-15.40%	-10.47%
Return on Common Equity (ROCE)	-38.83%	-28.85%	-28.18%	-19.60%	-18.93%	-25.03%	-16.87%	-19.99%	-21.21%	-17.11%	-11.44%
Return on Equity Simple (ROE_SIMPLE)	-47.89%	0.00%	-44.86%	-38.88%	-37.84%	0.00%	-28.90%	-26.73%	-24.19%	0.00%	-13.83%
Net Operating Profit after Tax (NOPAT)	-41	-36	-36	-30	-30	-34	-27	-32	-32	-26	-22
NOPAT Margin	-33.80%	-27.26%	-34.66%	-28.51%	-32.51%	-55.87%	-40.20%	-50.95%	-58.68%	-50.34%	-35.53%
Net Nonoperating Expense Percent (NNEP)	-6.55%	-10.96%	-4.40%	-2.86%	-3.36%	-5.69%	-3.91%	-3.80%	-3.17%	-2.30%	-2.19%
Return On Investment Capital (ROIC_SIMPLE)	-4.84%	-4.60%	-7.59%	-5.86%	-5.56%	-5.08%	-3.94%	-4.42%	-4.33%	-3.36%	-2.79%
Cost of Revenue to Revenue	71.24%	72.19%	73.29%	74.44%	73.94%	74.18%	77.88%	76.48%	88.42%	96.46%	86.57%
SG&A Expenses to Revenue	32.08%	30.30%	30.70%	28.73%	30.99%	43.15%	40.20%	46.28%	51.86%	46.43%	36.41%
R&D to Revenue	44.96%	36.45%	45.53%	37.56%	41.51%	62.49%	39.35%	50.02%	43.55%	29.01%	27.77%
Operating Expenses to Revenue	77.05%	66.75%	76.23%	66.29%	72.50%	105.64%	79.55%	96.30%	95.41%	75.45%	64.18%
Earnings before Interest and Taxes (EBIT)	-59	-50	-51	-42	-43	-48	-38	-44	-44	-37	-31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-50	-41	-42	-34	-35	-40	-31	-38	-38	-29	-23
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	18.80	33.29	11.51	5.20	4.17	4.85	3.61	4.70	3.02	2.65	2.73
Price to Tangible Book Value (P/TBV)	26.67	50.37	16.82	7.39	5.85	6.47	4.76	6.15	3.92	3.41	3.43
Price to Revenue (P/Rev)	17.40	29.19	13.28	7.24	7.07	10.99	8.96	12.39	8.57	8.46	10.22
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	23.38	41.59	0.00	0.00	0.00	7.35	5.78	8.53	5.34	4.76	5.34
Enterprise Value to Revenue (EV/Rev)	17.21	29.01	12.06	5.77	5.31	10.09	7.83	11.05	7.05	6.66	8.03
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	20.37	9.16	7.77	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.98	1.05	0.14	0.13	0.13	0.19	0.18	0.17	0.16	0.15	0.15
Long-Term Debt to Equity	0.94	1.02	0.11	0.11	0.11	0.16	0.00	0.00	0.16	0.15	0.14
Financial Leverage	-0.64	-0.32	-0.71	-0.74	-0.75	-0.49	-0.53	-0.57	-0.62	-0.71	-0.81
Leverage Ratio	2.68	2.27	2.09	2.04	1.94	1.57	1.52	1.50	1.49	1.44	1.42
Compound Leverage Factor	2.79	2.35	2.11	2.08	1.98	1.62	1.58	1.52	1.52	1.47	1.49
Debt to Total Capital	49.58%	51.21%	12.26%	11.89%	11.74%	15.96%	15.21%	14.59%	13.94%	13.26%	12.75%
Short-Term Debt to Total Capital	2.40%	1.54%	2.46%	2.20%	2.03%	2.69%	15.21%	14.59%	0.39%	0.37%	0.36%
Long-Term Debt to Total Capital	47.19%	49.68%	9.80%	9.69%	9.71%	13.27%	0.00%	0.00%	13.54%	12.89%	12.39%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	50.42%	48.79%	87.74%	88.11%	88.26%	84.04%	84.79%	85.41%	86.06%	86.74%	87.25%
Debt to EBITDA	-2.55	-2.65	-0.39	-0.44	-0.44	-0.72	-0.78	-0.81	-0.87	-1.10	-1.68
Net Debt to EBITDA	0.53	0.52	2.94	3.45	3.45	1.49	1.96	2.42	2.88	4.03	6.73
Long-Term Debt to EBITDA	-2.43	-2.57	-0.31	-0.36	-0.37	-0.60	0.00	0.00	-0.85	-1.07	-1.63
Debt to NOPAT	-2.94	-3.02	-0.45	-0.51	-0.52	-0.85	-0.90	-0.93	-1.00	-1.09	-1.19
Net Debt to NOPAT	0.61	0.59	3.42	3.98	4.06	1.76	2.27	2.77	3.30	3.99	4.79
Long-Term Debt to NOPAT	-2.80	-2.93	-0.36	-0.41	-0.43	-0.70	0.00	0.00	-0.97	-1.06	-1.16
Altman Z-Score	5.51	9.15	3.64	1.75	1.53	3.66	3.01	4.29	3.22	3.46	3.85
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.08	2.04	2.58	2.82	3.12	2.13	1.67	1.83	3.22	4.06	4.34
Quick Ratio	1.34	1.34	1.73	2.05	2.25	1.25	1.02	1.20	2.28	3.12	3.47
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-403	-4.47	309	297	285	-74	-67	-59	-99	-214	-325
Operating Cash Flow to CapEx	-189.19%	-11.07%	-280.59%	-84.72%	-13.50%	-405.39%	-119.74%	-57.36%	-200.29%	-126.37%	-275.45%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.38	0.41	0.35	0.30	0.26	0.25	0.24	0.23	0.22	0.21	0.19
Accounts Receivable Turnover	13.21	12.18	16.19	8.64	6.90	6.82	5.87	7.09	5.38	8.35	5.25
Inventory Turnover	3.01	2.82	2.48	2.37	2.15	1.93	2.11	2.13	2.31	2.74	2.62
Fixed Asset Turnover	2.57	2.56	2.37	2.37	2.31	1.98	2.06	2.14	2.30	2.53	2.52
Accounts Payable Turnover	7.04	7.77	7.98	9.36	8.73	9.34	10.39	10.02	10.73	24.66	21.05
Days Sales Outstanding (DSO)	27.64	29.96	22.54	42.26	52.89	53.53	62.17	51.47	67.82	43.70	69.46
Days Inventory Outstanding (DIO)	121.47	129.40	147.11	154.10	169.76	189.07	173.23	171.04	158.08	133.24	139.51
Days Payable Outstanding (DPO)	51.82	46.96	45.74	39.00	41.81	39.10	35.14	36.43	34.03	14.80	17.34
Cash Conversion Cycle (CCC)	97.29	112.39	123.91	157.36	180.84	203.50	200.26	186.08	191.87	162.15	191.64
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	343	304	-25	-27	-18	336	321	300	297	295	281
Invested Capital Turnover	2.87	1.36	2.46	2.39	2.03	0.78	0.79	0.81	0.85	1.05	1.44
Increase / (Decrease) in Invested Capital	362	-32	-346	-327	-315	41	40	28	67	188	303
Enterprise Value (EV)	8,021	12,655	4,387	1,884	1,500	2,468	1,852	2,561	1,587	1,406	1,499
Market Capitalization	8,109	12,733	4,832	2,365	1,997	2,687	2,117	2,872	1,930	1,784	1,909
Book Value per Share	$0.95	$0.77	$0.85	$0.92	$0.98	$1.14	$1.21	$1.28	$1.34	$1.42	$1.49
Tangible Book Value per Share	$0.67	$0.51	$0.58	$0.65	$0.70	$0.86	$0.92	$0.98	$1.03	$1.10	$1.19
Total Capital	855	784	479	517	543	660	691	715	744	776	802
Total Debt	424	401	59	61	64	105	105	104	104	103	102
Total Long-Term Debt	404	389	47	50	53	88	0.00	0.00	101	100	99
Net Debt	-88	-78	-445	-482	-497	-219	-265	-311	-343	-378	-410
Capital Expenditures (CapEx)	29	22	11	15	19	10	21	11	13	15	8.35
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-31	-54	-4.33	-0.02	12	26	19	17	42	30	38
Debt-free Net Working Capital (DFNWC)	397	365	438	497	504	271	308	359	441	502	541
Net Working Capital (NWC)	377	353	426	485	493	253	202	254	438	499	538
Net Nonoperating Expense (NNE)	19	16	16	11	14	17	13	14	13	11	12
Net Nonoperating Obligations (NNO)	-88	-78	-445	-482	-497	-219	-265	-311	-343	-378	-419
Total Depreciation and Amortization (D&A)	8.98	9.33	8.25	8.16	8.11	7.73	7.24	6.51	6.60	8.10	8.15
Debt-free, Cash-free Net Working Capital to Revenue	-6.69%	-12.34%	-1.19%	0.00%	4.12%	10.77%	8.12%	7.54%	18.73%	14.44%	20.51%
Debt-free Net Working Capital to Revenue	85.24%	83.71%	120.41%	152.06%	178.49%	110.84%	130.14%	154.75%	195.79%	238.04%	289.75%
Net Working Capital to Revenue	80.84%	80.95%	117.17%	148.59%	174.59%	103.58%	85.67%	109.71%	194.49%	236.67%	288.20%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.12)	($0.11)	($0.10)	($0.08)	($0.09)	($0.10)	($0.08)	($0.10)	($0.10)	($0.08)	($0.07)
Adjusted Weighted Average Basic Shares Outstanding	505.61M	495.93M	497.70M	494.19M	489.99M	481.77M	484.03M	479.74M	476.20M	466.21M	469.77M
Adjusted Diluted Earnings per Share	($0.12)	($0.11)	($0.10)	($0.08)	($0.09)	($0.10)	($0.08)	($0.10)	($0.10)	($0.08)	($0.07)
Adjusted Weighted Average Diluted Shares Outstanding	505.61M	495.93M	497.70M	494.19M	489.99M	481.77M	484.03M	479.74M	476.20M	466.21M	469.77M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	461.43M	453.55M	499.91M	496.64M	492.78M	489.14M	485.89M	483.33M	478.66M	477.65M	473.26M
Normalized Net Operating Profit after Tax (NOPAT)	-41	-36	-36	-30	-30	-34	-27	-32	-32	-26	-22
Normalized NOPAT Margin	-33.80%	-27.26%	-34.66%	-28.51%	-32.51%	-55.87%	-40.20%	-50.95%	-58.68%	-50.34%	-35.53%
Pre Tax Income Margin	-50.12%	-39.03%	-48.66%	-39.99%	-47.71%	-82.49%	-57.96%	-72.73%	-82.14%	-73.83%	-52.20%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-22.64%	-18.58%	-9.84%	-10.30%	-10.47%	-8.61%	-8.98%	-37.88%	-27.02%	-22.92%	-29.63%

Frequently Asked Questions About Rocket Lab USA's Financials

When does Rocket Lab USA's fiscal year end?

According to the most recent income statement we have on file, Rocket Lab USA's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Rocket Lab USA's net income changed over the last 4 years?

Rocket Lab USA's net income appears to be on an upward trend, with a most recent value of -$190.18 million in 2024, rising from -$55.01 million in 2020. The previous period was -$182.57 million in 2023. Find out what analysts predict for Rocket Lab USA in the coming months.

What is Rocket Lab USA's operating income?

Rocket Lab USA's total operating income in 2024 was -$189.80 million, based on the following breakdown:

Total Gross Profit: $116.15 million
Total Operating Expenses: $305.95 million

How has Rocket Lab USA revenue changed over the last 4 years?

Over the last 4 years, Rocket Lab USA's total revenue changed from $35.16 million in 2020 to $436.21 million in 2024, a change of 1,140.7%.

How much debt does Rocket Lab USA have?

Rocket Lab USA's total liabilities were at $801.89 million at the end of 2024, a 107.4% increase from 2023, and a 907.2% increase since 2020.

How much cash does Rocket Lab USA have?

In the past 4 years, Rocket Lab USA's cash and equivalents has ranged from $52.79 million in 2020 to $690.96 million in 2021, and is currently $271.04 million as of their latest financial filing in 2024.

How has Rocket Lab USA's book value per share changed over the last 4 years?

Over the last 4 years, Rocket Lab USA's book value per share changed from -4.39 in 2020 to 0.77 in 2024, a change of -117.4%.

Related Companies

This page (NASDAQ:RKLB) was last updated on 5/17/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rocket Lab USA (RKLB) Financials

Frequently Asked Questions About Rocket Lab USA's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Rocket Lab USA (RKLB) Financials

Annual Income Statements for Rocket Lab USA

Quarterly Income Statements for Rocket Lab USA

Annual Cash Flow Statements for Rocket Lab USA

Quarterly Cash Flow Statements for Rocket Lab USA

Annual Balance Sheets for Rocket Lab USA

Quarterly Balance Sheets for Rocket Lab USA

Annual Metrics And Ratios for Rocket Lab USA

Quarterly Metrics And Ratios for Rocket Lab USA

Frequently Asked Questions About Rocket Lab USA's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools